Health Care Price Transparency Makes It Easier for Patients to Shop Around

Patients can shop around for the best price on nearly everything they buy, but when it comes to health care, they are often expected to make expensive decisions without knowing what they will pay. New federal regulations from the Centers for Medicare & Medicaid Services (CMS) aim to give patients better access to health care prices and make it easier to compare costs before receiving treatment.

The new Transparency in Coverage rules build on requirements established during President Donald Trump's first term. They are intended to improve the accuracy, accessibility, and usefulness of pricing information that health insurers must disclose.

Price transparency is an essential part of creating a more consumer-driven health care system. When patients know what services cost and have greater control over their health care dollars, they are better positioned to make decisions that balance quality, affordability, and their household budgets.

Making Health Care Prices More Accessible

Federal rules have required health insurers to publish negotiated rates for covered medical services since 2022. However, the resulting pricing files have often been difficult for consumers and third-party developers to navigate, limiting their usefulness for comparing providers.

The new CMS regulations seek to address those problems by standardizing how prices are reported, improving data accuracy, and reducing unnecessary information. They also strengthen requirements for personalized cost estimates and make it easier for consumers to obtain information about their expected out-of-pocket expenses.

These improvements could make a practical difference for patients scheduling routine medical care. Someone comparing imaging centers, for example, should be able to identify differences in prices before deciding where to receive treatment.

Employers and technology developers also stand to benefit from more reliable pricing data. Employers can use the information to evaluate health plan costs, while developers can build comparison tools that make pricing information easier for patients to understand and use.

CMS has reported that prices among the most expensive 25% of health care services declined by 6.3% annually following implementation of earlier transparency requirements. While other factors may have contributed to those changes, the findings suggest that greater visibility into health care prices can support more competitive pricing.

Giving Patients the Ability to Shop for Better Value

Price competition is a normal part of most household purchases. Consumers compare grocery prices, evaluate housing costs, and consider competing offers when buying a vehicle. Businesses respond by competing on price, quality, and service.

Health care has not consistently operated under those same conditions. Insurance arrangements, complicated billing systems, and limited access to pricing information often separate patients from the actual cost of the services they receive.

Without clear pricing information, consumers have fewer opportunities to shop for better value, and providers face less competitive pressure to keep their prices affordable.

Greater transparency can begin to change that relationship. Patients seeking routine appointments, diagnostic testing, or other scheduled services should be able to compare providers and make informed decisions based on both cost and quality.

Not every medical expense lends itself to comparison shopping. Emergency care and certain complex treatments leave patients with fewer choices. However, a substantial range of planned medical services can be subject to the same competitive pressures that help control prices elsewhere in the economy.

Pairing Price Transparency With Health Savings Accounts

Better pricing information becomes more valuable when patients have a direct financial interest in how much their care costs.

Health savings accounts (HSAs) provide one way to strengthen that connection. These tax-advantaged accounts allow eligible individuals to save and spend money on qualified medical expenses while retaining unused funds for future health care needs.

People generally spend most efficiently when they are spending their own money on themselves. When patients can keep the savings from choosing a more affordable provider, they have a stronger incentive to compare prices and consider alternatives.

A patient who needs an MRI, for example, may find that several nearby providers offer the same procedure at significantly different prices. With transparent pricing and access to HSA funds, that patient can choose an appropriately qualified provider offering better value and preserve the remaining money for future expenses.

The same principle applies to other planned medical services. Giving patients more control over their spending encourages providers to compete for their business rather than relying on a system in which prices are difficult to discover and consumers have limited financial incentives to compare them.

Price transparency and HSAs therefore serve complementary purposes. Transparency gives consumers the information needed to evaluate their options, while HSAs give them a financial reason to seek better value.

CFE Takeaway

The new CMS price transparency rules represent progress toward a health care market in which patients have more information and greater control over their decisions.

Americans already compare prices and weigh competing options when spending their household budgets. They should have the same opportunity when purchasing medical care.

Price transparency alone will not resolve every problem contributing to rising health care costs. Its benefits will be greater when combined with consumer-driven policies, particularly expanded access to health savings accounts, that allow patients to control more of their own health care spending.

A system that gives consumers clear prices and meaningful choices can strengthen competition among providers, encourage more efficient spending, and help make health care more affordable.